The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9545396 B1

Expired

Date of Patent:

Jan. 17, 2017

Filed:

Sep. 29, 2013

mtor signaling pathway

Applicant:

Targeted Therapeutics, Llc, Buffalo Grove, IL (US);

Inventors:

Lei Duan, Evanston, IL (US);

Victor Levenson, Buffalo Grove, IL (US);

Guoguang Ying, Tianjin, CN;

Assignee:

Targeted Therapeutics, LLC, Buffalo Grove, IL (US);

Attorney:

Greer, Burns & Crain, Ltd.

Primary Examiner:

Marcos Sznaidman

Int. Cl.

CPC ...

A01N 43/36 (2006.01); A61K 31/40 (2006.01); A61K 31/436 (2006.01); A61K 31/7105 (2006.01); A61K 31/4025 (2006.01); A61K 31/381 (2006.01); C12N 15/113 (2010.01); A61K 45/06 (2006.01); A61K 31/4436 (2006.01); A61K 31/4439 (2006.01); A61K 31/7052 (2006.01);

U.S. Cl.

CPC ...

A61K 31/436 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/4436 (2013.01); A61K 31/4439 (2013.01); A61K 31/7052 (2013.01); A61K 31/7105 (2013.01); A61K 45/06 (2013.01); C12N 15/1137 (2013.01);

Abstract

The present invention relates to a pharmaceutical composition of PRCP antagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention also relates to a pharmaceutical composition jointly using PRCP antagonist and mTOR antagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention also relates to a method for utilizing the pharmaceutical compositions to treat and prevent cancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTOR signal pathway.

Find Patent Forward Citations

Duan, Lei. (2017). Method and pharmaceutical composition for inhibiting pi3k/akt/mtor signaling pathway (U.S. Patent No. 9545396). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9545396

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile